Cargando…

Insights into the role of STAT3 in intrahepatic cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) is a primary malignant liver tumour whose incidence is second only to that of hepatocellular carcinoma. ICC is a highly heterogeneous disease arising from neoplastic transformation of intrahepatic biliary epithelial cells (cholangiocytes), and it is characterize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ranzhiqiang, Song, Yinghui, Shakoor, Kashif, Yi, Weimin, Peng, Chuang, Liu, Sulai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971913/ https://www.ncbi.nlm.nih.gov/pubmed/35302174 http://dx.doi.org/10.3892/mmr.2022.12687

Ejemplares similares

The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022)

Correction to: The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022)

The new insight of treatment in Cholangiocarcinoma
por: Li, Yuhang, et al.
Publicado: (2022)

The pros and cons of the PCC staging system to guide surgical resectability and prognosis
por: Liu, Pei, et al.
Publicado: (2022)

Mechanisms underlying the changes in acetaldehyde dehydrogenase 1 in cholangiocarcinoma
por: Ding, Bai, et al.
Publicado: (2023)

MicroRNA-129-2-3p directly targets Wip1 to suppress the proliferation and invasion of intrahepatic cholangiocarcinoma
por: Chen, Chen, et al.
Publicado: (2020)

A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing
por: Chen, Xu, et al.
Publicado: (2023)

iNOS is associated with tumorigenicity as an independent prognosticator in human intrahepatic cholangiocarcinoma
por: Liu, Sulai, et al.
Publicado: (2019)

The role of microRNAs in intrahepatic cholangiocarcinoma
por: Li, Zheng, et al.
Publicado: (2016)

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
por: Fiste, Oraianthi, et al.
Publicado: (2021)

Wip1 is associated with tumorigenity and metastasis through MMP-2 in human intrahepatic cholangiocarcinoma
por: Liu, Sulai, et al.
Publicado: (2017)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Role of Percutaneous Ablation in the Management of Intrahepatic Cholangiocarcinoma
por: Charalampopoulos, Georgios, et al.
Publicado: (2023)

STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome
por: Xin-wei, Yang, et al.
Publicado: (2016)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017)

Surgical Aspects of Intrahepatic Cholangiocarcinoma
por: Kupietzky, Amram, et al.
Publicado: (2022)

Locoregional Therapy for Intrahepatic Cholangiocarcinoma
por: Owen, Mackenzie, et al.
Publicado: (2023)

Application of Laparoscopic Radical Resection for Type III and IV Hilar Cholangiocarcinoma Treatment
por: Liu, Sulai, et al.
Publicado: (2020)

Intrahepatic cholangiocarcinoma: Evolving role of neoadjuvant and targeted therapy
por: Ghio, Michael, et al.
Publicado: (2023)

The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma
por: Panayotova, Guergana, et al.
Publicado: (2021)

Locoregional Therapy for Intrahepatic Cholangiocarcinoma: The Role of Intra-Arterial Therapies
por: Gorji, Leva, et al.
Publicado: (2023)

Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3
por: Zhou, Zhengjun, et al.
Publicado: (2021)

NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis
por: Lu, Shounan, et al.
Publicado: (2022)

Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
por: Chun, Yun Shin, et al.
Publicado: (2017)

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Massarweh, Nader N., et al.
Publicado: (2017)

Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma
por: Akateh, Clifford, et al.
Publicado: (2020)

Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
por: Serifis, Nikolaos, et al.
Publicado: (2021)

The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma
por: Zhou, Qi, et al.
Publicado: (2013)

Intrahepatic Cholangiocarcinoma: State of the Art of FGFR Inhibitors
por: Wu, Tianyu, et al.
Publicado: (2021)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
por: Auer, Timo Alexander, et al.
Publicado: (2023)

Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma
por: Chen, Xing, et al.
Publicado: (2022)

Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Jeong, Seogsong, et al.
Publicado: (2016)

Vascular Resection for Intrahepatic Cholangiocarcinoma: Current Considerations
por: Alikhanov, Ruslan, et al.
Publicado: (2021)

Molecular Subtypes and Precision Oncology in Intrahepatic Cholangiocarcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach
por: Krenzien, Felix, et al.
Publicado: (2022)

Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma
por: Zhao, Linghao, et al.
Publicado: (2022)

Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3’-methyl-4 dimethylaminoazobenzene in rats
por: Zhang, Fan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0s594ahukadsqp7g98s3e21stu